ARDELYX, INC. Net Income (Loss) Available to Common Stockholders, Diluted
ARDELYX, INC. (ARDX) reported Net Income (Loss) Available to Common Stockholders, Diluted of $9.01 million for the 3-month period ending 2015-06-30, per its 10-Q filed 2015-08-12.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2015-08-12
- ARDELYX, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2015-06-30 was $9.01M, a 1181.22% increase year-over-year.
- ARDELYX, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2014-09-30 was $74.00K.
- ARDELYX, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2014-06-30 was $703.00K.
- ARDELYX, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2013-09-30 was -$934.00K.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month |
|---|---|---|---|
| 2015-06-30 | $9.01M 10-Q · filed 2015-08-12 | $5.50M 10-Q · filed 2015-08-12 | |
| 2014-09-30 | $74.00K 10-Q · filed 2014-11-07 | $777.00K derived: sum of 2 quarters · filed 2015-08-12 | |
| 2014-06-30 | $703.00K 10-Q · filed 2015-08-12 | $0.00 10-Q · filed 2015-08-12 | |
| 2013-09-30 | -$934.00K 10-Q · filed 2014-11-07 | -$1.82M derived: sum of 2 quarters · filed 2014-11-07 | -$2.29M 10-Q · filed 2014-11-07 |
| 2013-06-30 | -$891.00K 10-Q · filed 2014-08-08 | -$1.36M 10-Q · filed 2014-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |